Seegene Inc.

Seegene, Inc., headquartered in Seoul, leads in global molecular diagnostics with a broad IVD portfolio covering respiratory, GI, STI, TB, drug‑resistance, and sepsis tests. Its automated platforms and qPCR synergies position it for expanding precision‑medicine markets.

Headquarters: South Korea (KOR)

Seegene Inc. Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
096530 Seegene Inc.
Cap: 1145.9B
EQUITY KOE KRW KR7096530001 Active
📈
Home Login